Michel Detheux, Chief Executive Officer at iTeos Therapeutics, Inc. (ITOS), sold 58,000 shares at $28.38 ($1.7M) on 2021-06-14, disclosed to the SEC on 2021-06-16.
Open-market sale of $1.7M ITOS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.38 | 25,063 | $711K | 43.0% |
| 2 | $28.38 | 25,063 | $711K | 43.0% |
| 3 | $29.26 | 3,937 | $115K | 7.0% |
| 4 | $29.26 | 3,937 | $115K | 7.0% |
| Total | $28.50 avg | 58,000 | $1.7M | 100% |
| Filing → |
| ITOS | SELL | 2022-04-19 | $732K | — | Filing → |
| ITOS | SELL | 2022-03-22 | $1.2M | — | Filing → |
| ITOS | SELL | 2022-02-24 | $977K | — | Filing → |